Silverback Asset Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Silverback Asset Management's DFTX Position: Q3 2026 in Review
Silverback Asset Management opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 15,000 shares worth $571K. The stake represents 0.04% of the portfolio and ranks #60 among its holdings.
354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Silverback Asset Management held 15,000 shares of Definium Therapeutics worth $571K as of Q3 2026.
- Definium Therapeutics was a new Silverback Asset Management position in Q3 2026.
- Definium Therapeutics made up 0.04% of Silverback Asset Management's portfolio in Q3 2026, its #60 holding.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Silverback Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.